Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2010 Mar 23;33(6):1193–1199. doi: 10.2337/dc09-1888

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2010 by the American Diabetes Association.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ for details.

PMC Copyright notice

Results of the probabilistic sensitivity analyses for the cost-effectiveness of aspirin use in newly diagnosed type 2 diabetes. A: Using parameters for general population in the ATT study. B: Using parameters for diabetes subgroup in the meta-analysis by De Berardis et al. (13). Plot of incremental cost versus incremental QALYs for aspirin use versus no aspirin use. Each dot on the graph represents one ICER from one of the 1,000 iterations. Solid line represents ICER = $50,000/QALY; dotted line represents ICER = $20,000/QALY. Dots on the right of the lines mean that the ICERS are less than the ICER the line represents. Dots in quadrant 1 show that the intervention is more effective and less costly; dots in quadrant 4 show that the intervention is cost saving.